Insider · CIK 0001665347

Hooks Corwin Dale

Reports to the SEC for 3 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001665347

Forms 4 and 5

Insider transactions

42 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-09	SPRBSPRUCE BIOSCIENCES, INC. · Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	+11K sh	—	—	11,000
2026-02-03	APLTApplied Therapeutics, Inc.D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−863K sh	—	—	5,753
2026-02-03	APLTApplied Therapeutics, Inc.U Disposition from Tender	Chief Commercial Officer	UDisposition from Tender	−5,753 sh	—	—	0
2025-12-19	APLTApplied Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+313K sh	—	—	868,253
2025-03-24	APLTApplied Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+250K sh	—	—	550,000
2024-04-12	APLTApplied Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+300K sh	—	—	300,000
2018-09-05	Clovis Oncology, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−469 sh	—	—	4,688
2018-09-05	Clovis Oncology, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+469 sh	—	—	5,588
2018-09-05	Clovis Oncology, Inc.F Tax Payment	See Remarks	FTax Payment	−239 sh	$35.75	−$8,544.25	5,349
2018-08-27	Clovis Oncology, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−869 sh	—	—	6,950
2018-08-27	Clovis Oncology, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+869 sh	—	—	5,553
2018-08-27	Clovis Oncology, Inc.F Tax Payment	See Remarks	FTax Payment	−434 sh	$35.15	−$15.3K	5,119
2018-06-15	Clovis Oncology, Inc.S Sale	See Remarks	SSale	−939 sh	$45.47	−$42.7K	1,595
2018-06-06	Clovis Oncology, Inc.F Tax Payment	See Remarks	FTax Payment	−235 sh	$47.70	−$11.2K	4,684
2018-06-06	Clovis Oncology, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+468 sh	—	—	4,919
2018-06-06	Clovis Oncology, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−468 sh	—	—	5,157
2018-05-31	Clovis Oncology, Inc.F Tax Payment	See Remarks	FTax Payment	−444 sh	$48.63	−$21.6K	4,451
2018-05-31	Clovis Oncology, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+869 sh	—	—	3,958
2018-05-31	Clovis Oncology, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−869 sh	—	—	7,819
2018-03-07	Clovis Oncology, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−1,875 sh	—	—	5,625
2018-03-07	Clovis Oncology, Inc.F Tax Payment	See Remarks	FTax Payment	−938 sh	$58.43	−$54.8K	4,026
2018-03-07	Clovis Oncology, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+1,875 sh	—	—	4,964
2018-03-01	Clovis Oncology, Inc.F Tax Payment	See Remarks	FTax Payment	−467 sh	$55.51	−$25.9K	3,089
2018-03-01	Clovis Oncology, Inc.Stock Option (right to buy)A Award	See Remarks	AAward	+9,000 sh	—	—	9,000
2018-03-01	Clovis Oncology, Inc.Restricted Stock UnitsA Award	See Remarks	AAward	+9,000 sh	—	—	9,000
2018-03-01	Clovis Oncology, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+869 sh	—	—	3,556
2018-03-01	Clovis Oncology, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−869 sh	—	—	8,688
2017-11-29	Clovis Oncology, Inc.F Tax Payment	See Remarks	FTax Payment	−331 sh	$59.49	−$19.7K	2,687
2017-11-29	Clovis Oncology, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−868 sh	—	—	9,557
2017-11-29	Clovis Oncology, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+868 sh	—	—	3,018
2017-08-31	Clovis Oncology, Inc.S Sale	See Remarks	SSale	−2,150 sh	$76.36	−$164K	19
2017-08-29	Clovis Oncology, Inc.F Tax Payment	See Remarks	FTax Payment	−1,325 sh	$72.14	−$95.6K	2,150
2017-08-25	Clovis Oncology, Inc.F Tax Payment	See Remarks	FTax Payment	−1,306 sh	$73.16	−$95.5K	2,169
2017-08-25	Clovis Oncology, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−3,475 sh	—	—	10,425
2017-08-25	Clovis Oncology, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+3,475 sh	—	—	3,475
2017-03-27	Clovis Oncology, Inc.Stock Option (right to buy)A Award	See Remarks	AAward	+15K sh	—	—	15,000
2017-03-27	Clovis Oncology, Inc.Restricted Stock UnitsA Award	See Remarks	AAward	+7,500 sh	—	—	7,500
2016-08-25	Clovis Oncology, Inc.Restricted Stock UnitsA Award	See Remarks	AAward	+13.9K sh	—	—	13,900
2016-08-25	Clovis Oncology, Inc.Stock Option (right to buy)A Award	See Remarks	AAward	+27.8K sh	—	—	27,800
2016-03-01	Clovis Oncology, Inc.Stock option (right to buy)A Award	See Remarks	AAward	+10K sh	—	—	10,000
2016-02-01	Clovis Oncology, Inc.Stock option (right to buy)A Award	See Remarks	AAward	+10K sh	—	—	10,000
2016-02-01	Clovis Oncology, Inc.Stock option (right to buy)A Award	See Remarks	AAward	+10K sh	—	—	10,000

Recent filings

Accepted (ET)
Mar 94
Hooks Corwin Dale0001665347-26-000006
SEC(opens sec.gov)
Feb 34
Hooks Corwin Dale0001193125-26-036198
SEC(opens sec.gov)
Mar 264
Hooks Corwin Dale0000950170-25-045617
SEC(opens sec.gov)
Apr 154
Hooks Corwin Dale0000950172-24-000190
SEC(opens sec.gov)
Dec 274
Hooks Corwin Dale0000899243-18-031841
SEC(opens sec.gov)
Dec 274
Hooks Corwin Dale0000899243-18-031839
SEC(opens sec.gov)
Sep 74
Hooks Corwin Dale0000899243-18-024003
SEC(opens sec.gov)
Aug 284
Hooks Corwin Dale0000899243-18-023428
SEC(opens sec.gov)
Jun 84
Hooks Corwin Dale0000899243-18-015794
SEC(opens sec.gov)
Jun 14
Hooks Corwin Dale0000899243-18-014684
SEC(opens sec.gov)

Companies

Address

C/O SPRUCE BIOSCIENCES, INC. 611 GATEWAY BOULEVARD, SUITE 740

SOUTH SAN FRANCISCO, CA, 94080